Jeanne M Marrazzo
Biographic Data
| ID | 6056610 |
|---|---|
| NAME | Jeanne M Marrazzo |
| GIVEN NAMES | Jeanne M |
| FAMILY NAME | Marrazzo |
| SIGNATURE | MARRAZZO J M |
| AFFILIATIONS | Devika Singh and Jeanne M. Marrazzo are with the Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle. David N. Fine is with the Center for Health Training, Seattle. |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 1 |
Uptake and Persistence of Safer Conception Strategies Among South African Women Planning for Pregnancy
Safer conception strategies can minimize HIV acquisition during periconception periods among women living in HIV-endemic areas. We examined uptake and predictors of persistent use of the same safer conception strategy among a cohort of HIV-uninfected South African women ages 18-35 years planning for pregnancy with a partner living with HIV or of unknown HIV-serostatus. The safer conception strategies we evaluated included oral PrEP, condomless se…
I still desire to have a child’
This study explored the intersecting forms of stigma experienced by HIV-serodifferent couples with unmet reproductive goals in rural Uganda. The parent mixed-methods study, which included 131 HIV-exposed women with plans for pregnancy, offered comprehensive HIV prevention counselling and care over a nine-month period. In-depth interviews were conducted with 37 women and seven male partners to explore care experiences and the use of safer concepti…
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
BACKGROUND: Reproductive-age women need effective interventions to prevent the acquisition of human immunodeficiency virus type 1 (HIV-1) infection. METHODS: We conducted a randomized, placebo-controlled trial to assess daily treatment with oral tenofovir disoproxil fumarate (TDF), oral tenofovir-emtricitabine (TDF-FTC), or 1% tenofovir (TFV) vaginal gel as preexposure prophylaxis against HIV-1 infection in women in South Africa, Uganda, and Zimb…
Chlamydia trachomatis Infection Among Women Reporting Sexual Activity With Women Screened in Family Planning Clinics in the Pacific Northwest, 1997 to 2005
Objectives. We sought to define Chlamydia trachomatis positivity among women who report sexual activity with women, a population for which sparse data on this infection are available and for whom health disparities including challenged access to comprehensive sexual and reproductive health services, have been reported. Methods. We analyzed data from 9358 family planning clinic visits with C trachomatis tests among women aged 15 to 24 years who re…
Chlamydia trachomatis Infection Among Women Reporting Sexual Activity With Women Screened in Family Planning Clinics in the Pacific Northwest, 1997 to 2005
Objectives. We sought to define Chlamydia trachomatis positivity among women who report sexual activity with women, a population for which sparse data on this infection are available and for whom health disparities including challenged access to comprehensive sexual and reproductive health services, have been reported. Methods. We analyzed data from 9358 family planning clinic visits with C trachomatis tests among women aged 15 to 24 years who re…
Chlamydia trachomatis Infection Among Women Reporting Sexual Activity With Women Screened in Family Planning Clinics in the Pacific Northwest, 1997 to 2005
Objectives. We sought to define Chlamydia trachomatis positivity among women who report sexual activity with women, a population for which sparse data on this infection are available and for whom health disparities including challenged access to comprehensive sexual and reproductive health services, have been reported. Methods. We analyzed data from 9358 family planning clinic visits with C trachomatis tests among women aged 15 to 24 years who re…
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
BACKGROUND: Reproductive-age women need effective interventions to prevent the acquisition of human immunodeficiency virus type 1 (HIV-1) infection. METHODS: We conducted a randomized, placebo-controlled trial to assess daily treatment with oral tenofovir disoproxil fumarate (TDF), oral tenofovir-emtricitabine (TDF-FTC), or 1% tenofovir (TFV) vaginal gel as preexposure prophylaxis against HIV-1 infection in women in South Africa, Uganda, and Zimb…
I still desire to have a child’
This study explored the intersecting forms of stigma experienced by HIV-serodifferent couples with unmet reproductive goals in rural Uganda. The parent mixed-methods study, which included 131 HIV-exposed women with plans for pregnancy, offered comprehensive HIV prevention counselling and care over a nine-month period. In-depth interviews were conducted with 37 women and seven male partners to explore care experiences and the use of safer concepti…
Uptake and Persistence of Safer Conception Strategies Among South African Women Planning for Pregnancy
Safer conception strategies can minimize HIV acquisition during periconception periods among women living in HIV-endemic areas. We examined uptake and predictors of persistent use of the same safer conception strategy among a cohort of HIV-uninfected South African women ages 18-35 years planning for pregnancy with a partner living with HIV or of unknown HIV-serostatus. The safer conception strategies we evaluated included oral PrEP, condomless se…
Medicine (4 works) · Adolescent Sexual and Reproductive Health (3 works) · Environmental health (3 works) · HIV/AIDS Research and Interventions (3 works) · Population (3 works) · Demography (2 works) · Family medicine (2 works) · Fertility (2 works) · Immunology (2 works) · Nursing (2 works)